Prerandomization run-in periods in randomized controlled trials of chronic diseases: a methodological study
<p><strong>OBJECTIVE:</strong> To systematically review the epidemiology of prerandomized run-in periods in randomized controlled trials (RCTs) of chronic diseases.</p> <p><strong>STUDY DESIGN AND SETTING:</strong> Meta-epidemiologic study of all RCTs from...
Main Authors: | Collister, D, Rodrigues, JC, Mbuagbaw, L, Devereaux, PJ, Guyatt, G, Herrington, W, Walsh, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2020
|
Similar Items
-
Use of run-in periods in randomized trials
by: Huo, X, et al.
Published: (2020) -
Effect of a Run‐In Period on Estimated Treatment Effects in Cardiovascular Randomized Clinical Trials: A Meta‐Analytic Review
by: Robert P. Murphy, et al.
Published: (2022-10-01) -
Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial
by: Preiss, D, et al.
Published: (2022) -
Determination of Methodology and Research of the Influence of the Trial Run of High-Precision Reducers on the Change of Their Characterizing Properties
by: Marek Kočiško, et al.
Published: (2021-04-01) -
Acute treatment effects on GFR in randomized clinical trials of kidney disease progression
by: Neuen, B, et al.
Published: (2021)